PL3296294T3 - Związek do leczenia lub zapobiegania nowotworowi piersi - Google Patents
Związek do leczenia lub zapobiegania nowotworowi piersiInfo
- Publication number
- PL3296294T3 PL3296294T3 PL16792124T PL16792124T PL3296294T3 PL 3296294 T3 PL3296294 T3 PL 3296294T3 PL 16792124 T PL16792124 T PL 16792124T PL 16792124 T PL16792124 T PL 16792124T PL 3296294 T3 PL3296294 T3 PL 3296294T3
- Authority
- PL
- Poland
- Prior art keywords
- treating
- compound
- breast cancer
- preventing breast
- preventing
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D293/12—Selenazoles; Hydrogenated selenazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510239715 | 2015-05-09 | ||
| PCT/CN2016/081241 WO2016180274A1 (zh) | 2015-05-09 | 2016-05-06 | 用于治疗或预防乳腺癌的化合物 |
| EP16792124.6A EP3296294B1 (en) | 2015-05-09 | 2016-05-06 | Compound for treating or preventing breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3296294T3 true PL3296294T3 (pl) | 2020-08-24 |
Family
ID=56913857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16792124T PL3296294T3 (pl) | 2015-05-09 | 2016-05-06 | Związek do leczenia lub zapobiegania nowotworowi piersi |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10005744B2 (pl) |
| EP (1) | EP3296294B1 (pl) |
| JP (2) | JP6618550B2 (pl) |
| CN (1) | CN105949149B (pl) |
| ES (1) | ES2779465T3 (pl) |
| PL (1) | PL3296294T3 (pl) |
| PT (1) | PT3296294T (pl) |
| WO (1) | WO2016180274A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016180274A1 (zh) * | 2015-05-09 | 2016-11-17 | 江苏新元素医药科技有限公司 | 用于治疗或预防乳腺癌的化合物 |
| CN111170962B (zh) * | 2018-11-12 | 2023-05-23 | 江苏新元素医药科技有限公司 | 4-(苯并硒唑-2-基)芳胺类化合物治疗肠癌的用途 |
| CN111170963B (zh) * | 2018-11-12 | 2023-05-23 | 江苏新元素医药科技有限公司 | 4-(苯并硒唑-2-基)芳胺类化合物治疗胃癌的用途 |
| WO2020098517A1 (zh) * | 2018-11-12 | 2020-05-22 | 江苏新元素医药科技有限公司 | 4-(苯并硒唑-2-基)芳胺类化合物治疗胃癌或肠癌的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861424A (en) * | 1991-04-26 | 1999-01-19 | Dana Farber Cancer Institute | Composition and method for treating cancer |
| GB9317949D0 (en) * | 1993-08-28 | 1993-10-13 | Stevens Malcolm F G | Benzothiazole compounds |
| US6110929A (en) * | 1998-07-28 | 2000-08-29 | 3M Innovative Properties Company | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| GB9919673D0 (en) * | 1999-08-20 | 1999-10-20 | Cancer Res Campaign Tech | 2-Arlybenzazole compounds |
| WO2009039553A1 (en) * | 2007-09-27 | 2009-04-02 | The Walter And Eliza Hall Institute Of Medical Research | Benzothiazole compounds |
| CN102617478B (zh) * | 2011-01-31 | 2015-07-15 | 华东理工大学 | 苯并咪唑、噁唑和噻唑衍生物的合成及其应用 |
| WO2015051188A1 (en) * | 2013-10-02 | 2015-04-09 | Washington University | Heterocyclic molecules for biomedical imaging and therapeutic applications |
| WO2016180274A1 (zh) * | 2015-05-09 | 2016-11-17 | 江苏新元素医药科技有限公司 | 用于治疗或预防乳腺癌的化合物 |
-
2016
- 2016-05-06 WO PCT/CN2016/081241 patent/WO2016180274A1/zh not_active Ceased
- 2016-05-06 PL PL16792124T patent/PL3296294T3/pl unknown
- 2016-05-06 ES ES16792124T patent/ES2779465T3/es active Active
- 2016-05-06 JP JP2017559455A patent/JP6618550B2/ja active Active
- 2016-05-06 CN CN201610299350.1A patent/CN105949149B/zh active Active
- 2016-05-06 PT PT167921246T patent/PT3296294T/pt unknown
- 2016-05-06 US US15/572,760 patent/US10005744B2/en active Active
- 2016-05-06 EP EP16792124.6A patent/EP3296294B1/en active Active
-
2019
- 2019-06-19 JP JP2019113688A patent/JP6974869B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN105949149A (zh) | 2016-09-21 |
| JP6618550B2 (ja) | 2019-12-11 |
| JP2018515540A (ja) | 2018-06-14 |
| US10005744B2 (en) | 2018-06-26 |
| EP3296294A1 (en) | 2018-03-21 |
| PT3296294T (pt) | 2020-05-13 |
| JP6974869B2 (ja) | 2021-12-01 |
| JP2019196362A (ja) | 2019-11-14 |
| EP3296294B1 (en) | 2020-02-12 |
| ES2779465T3 (es) | 2020-08-17 |
| US20180134673A1 (en) | 2018-05-17 |
| CN105949149B (zh) | 2018-08-24 |
| WO2016180274A1 (zh) | 2016-11-17 |
| EP3296294A4 (en) | 2018-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL298497B1 (en) | A method for treating cancer | |
| SG11201708861VA (en) | Methods for treating cancer | |
| IL254705A0 (en) | Combination therapy for cancer | |
| SI3377516T1 (sl) | Sestavek za zdravljenje raka | |
| IL255060A0 (en) | Combined treatment for cancer | |
| IL249229A0 (en) | Compounds for the treatment of brain cancer | |
| IL259996A (en) | Combinations for cancer treatment | |
| IL257691A (en) | A method for treating cancer | |
| PT3197456T (pt) | Tratamentos de cancro | |
| IL256836B (en) | Methods for treating cancer using apilimod | |
| IL255022A0 (en) | Cancer treatment methods | |
| IL255079A0 (en) | Methods of treating lung cancer | |
| IL255018A0 (en) | Cancer treatment methods | |
| ZA201707024B (en) | Cancer treatment composition | |
| IL255016A0 (en) | Cancer treatment methods | |
| PT3296294T (pt) | Composto para tratamento ou prevenção do cancro de mama | |
| IL260814A (en) | Cancer treatment | |
| GB201522433D0 (en) | Cancer treatment | |
| PL3236961T3 (pl) | Kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu złośliwego | |
| SG10201508795XA (en) | Method for treating cancer | |
| IL259097A (en) | Combination therapy for cancer | |
| IL255167A0 (en) | Compounds for the treatment of cancer | |
| ZA201704589B (en) | Compounds for the treatment of cancer | |
| HRP20210383T8 (hr) | Kombinirana terapija za rak | |
| GB201514777D0 (en) | Cancer Treatments |